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1. Introduction
Physicians, by nature, seem to strive for more precise means to diagnose, quantify and manage
chronic disease. It seems intuitive that doing so will help us diagnose earlier, have an increased
understanding for the relative severity of disease in individual patients and, ultimately,
through more timely diagnosis, mitigate morbidities associated with that disease. In the
example of diabetes, we can now look at glycosylated hemoglobin levels (HbA1c) and derive
a reasonable understanding of risk level and relative treatment success for individual patients.
While the HbA1c value is not flawless as a metric, it has become an extremely robust and
accepted tool in diabetes management. Our efforts to coalesce ocular physical measurements
with functional values seem to point to our desire to define glaucoma in one simple value.
While the effort itself has already shed great benefits to our understanding of this complex
disease, it ultimately seems unlikely that we will ever be able to adequately define glaucoma
in terms of a singular value.
During the past century, the metrics used to diagnose and manage glaucoma have varied and
evolved. In the 1950’s, using Schiotz tonometry, Leydecker showed that approximately 2.5%
of the population had intraocular pressures greater than 21mm Hg. It was also determined
that a similar number of people in that study had glaucoma. From that point forward, 21mm
Hg became the empirical metric for determining who was at risk. More than fifty years has
passed since the publication of Leydecker’s study and a cornucopia of compelling scientific
literature has been presented which has shed light on the diversity and complexity of glaucoma
and clearly diminishes its relevance as a stand-alone diagnostic feature. Ironically, the vast
body of evidence which clearly discourages reliance of the old 21 mm red flag in glaucoma
diagnosis seems not to have been sufficient to clear it from the minds and hearts of too many
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eye doctors in this century. It would appear that we have an inner need to strive for and adhere
to simple answers to even the most complex problems.
Figure 1. CURRENT SIGNIFICANCE OF 21 mmHg: The distribution of IOP in the general population as studied by Ley‐
decker (normal IOP was statistically defined two standard deviations above and below mean, as 11-21 mmHg) is not
Gaussian, but is slightly skewed towards higher IOP’s [1]
Beyond the early observation that glaucomatous vision loss is generally accompanied with
high intraocular pressure, scientists began to observe the physical changes within the eye that
seemed to occur in concert with that loss. In 1885, Priestley Smith elegantly defined glaucoma,
stating that “The excavation of the disc in glaucoma is not a purely mechanical result of exalted
pressure; it is, in part at least, an atrophic condition which, though primarily due to pressure,
includes vascular changes and impaired nutrition of the substance of the optic disc… which
may possibly progress even though all excessive pressure be removed”. Given this under‐
standing, eye doctors started to look for tools to study the eye and its function in greater detail.
Today, eye doctors are challenged with a new puzzle. In current clinical practive we can obtain
physical and psychometric data that was previously unimaginable. We are still attempting to
determine which of the vast data has the greatest utility and specificity in regard to the
diagnosis, quantification and management of glaucoma.
2. Observation and measurement of structure
2.1. Ophthalmoscopy
Understandably, long before doctors could document the eye’s interior contents with imaging
techniques, observation and evaluation of the nerve was performed by ophthalmoscopy.
Observations were recorded with drawings. Though others produced earlier versions of the
ophthalmoscope, in 1851, Hermann von Helmholtz reported its usefulness and, therein,
revolutionized ophthalmology.
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Figure 2. Early Welsh Allyn ophthalmoscope
In 1915, Francis A. Welch and William Noah Allyn invented the world's first hand-held direct
illuminating ophthalmoscope, precursor to the device now used by clinicians around the
world. This refinement and updating of von Helmholtz's invention enabled ophthalmoscopy
to become one of the most ubiquitous medical screening techniques in the world today. The
company started as a result of this invention is Welch Allyn. [2]
The need for stereopsis arose soon after the discovery of the ophthalmoscope. Given the
limitations of a two dimensional view, the glaucomatous cup was, at first, mistaken for a
swelling. At that time, Brewster's popular stereoscope was introduced, and its theory and
method were then applied to ophthalmoscopy by Giraud-Teulon. His was the first binocular
instrument, subsequently much improved by Zachariah Laurence. Binocular indirect oph‐
thalmoscopy was abandoned toward the end of the 19th century in favor of direct monocular
ophthalmoscopy, until it was revived in the 1950s by Schepens. More recently, hand held
biomicroscopic lenses, which were popularized in the late 1980’s by Volk Optical, Inc., are now
a clinical standard for indirect three dimensional observations and evaluation of the nerve. [3]
3. Disc documentation
3.1. Drawings
Having the ability to view the nerve in vivo, proper scientific method deemed it necessary to
document of these observations. For the better part of the twentieth century, manual drawing
of the disc remained the clinical standard.
While disc drawing and careful direct observation of the nerve still have significant benefits,
our scientific curiosity and our frank understanding of the likelihood of human variability and
error with manual drawings, has driven us to develop methods of observation and recording
which yield information down to the cellular level and render documentation which is
relatively free of the obvious variability in individual observer skill and methodology.
Before the mid 1970’s, eye doctors, in training, could not yet see photographs of the live human
retina. Ophthalmic texts traditionally included drawings of normal and pathological eyes,
which were rendered by professional medical artists.
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Figure 3. Typical clinician’s disc drawing
Figure 4. Medical artist’s disc drawing of glaucomatous optic nerve
3.2. Photography
With fundus photography becoming commonplace by the early 1980’s, stereo disc photogra‐
phy became possible and earned its place as the clinical gold standard in optic nerve docu‐
mentation for the remainder of the twentieth century.
Recently, digital two and three dimensional photography have quickly outpaced conventional
film photography of the nerve because of its obvious advantages in efficiency, economy and
portability.
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Figure 5. Optic nerve photograph
Figure 6. Simultaneous digital stereo disc photograph captured using the Nidek 3-DX system
3.3. Beyond photography
While photography had given us robust methodology for documentation of the appearance
of the optic nerve head, it seemed natural to look for ways to numerically quantify various
nerve attributes. An early attempt called the Glaucomascope, cast a series of infrared bars
across the surface of the nerve. The variation in line contours signaled the instrument to make
calculations regarding cup dimensions and, hopefully, track topographical change in con‐
cordance with glaucoma progression. The next generation of devices including the GDX (Carl
Ziess) and the Heidelberg Retinal Tomograph (HRT) (Heidelberg Engineering), provided a
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more comprehensive perspective of nerve attributes and, with GDX, added new measure‐
ments of the nerve fiber layer surrounding the papilla. The HRT was the first to incorporate
nerve progression analysis.
Figure 7. HRT 3-D image of the optic nerve and retinal nerve fiber layer (RNFL)
The Heidelberg Retina Tomograph (HRT) is a confocal scanning laser ophthalmoscope. A laser
light scans the retina in 24 millisecond sequential scans, starting above the retinal surface, then
capturing parallel images at increasing depths. The stacks of images can be combined to create
a three-dimensional (3-D) topographic image of the retina. Images are aligned and compared
using TruTrack™ software for both individual examinations and for detecting change between
examinations.
When applying the technology to glaucoma, the HRT takes data from a 3-D stack of tomo‐
graphic images of the optic nerve and retinal nerve fiber layer (RNFL), aligns the images and
computes a 3-D topographic map of the surface of the retina. This 3-D topographic map is
analyzed for signs of glaucomatous damage and the results are displayed on either a single
eye examination report or on an OU examination report.
The GDx nerve fiber analyzers measures the retinal nerve fiber layer (RNFL) thickness with a
scanning laser polarimeter based on the birefringent properties of the RNFL. Measurement is
obtained from a band 1.75 disc diameters concentric to the disc.
The GDx projects a polarized beam of a light into the eye. As this light passes through the NFL
tissue, it changes in speed. The detectors measure the change and convert it into thickness units
that are graphically displayed. The GDx measures modulation around an ellipse just outside
the optics disc and ratios of the thickest points either superiorly or inferiorly to the temporal
or nasal regions.
The state of polarization of the light is change (retardation) as it passes through birefringent
tissue (cornea and RNFL). Corneal birefringence is eliminated (in part) by a propriety ‘corneal
compensator’. The amount of retardation of light reflected from the fundus is converted to
RNFL thickness.
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A Dutch study found that while there is a correlation between standard automated perimetry
and GDx, variable corneal compensation (VCC) measurements in patients with glaucoma,
suggesting that GDx VCC measurements relate well with functional loss in glaucoma. In
healthy subjects, they found virtually no correlation between perimetry and GDx VCC
measurements. This would cast doubt on its predictive value and suggests false positives. [4]
4. Ocular Coherence Tomography (OCT) – the new gold standard
Optical coherence tomography (OCT) has advanced considerably since it was first applied to
the eye. It is an extension of a technique called low-coherence interferometry, which was
initially applied to ophthalmology for in vivo measurements of eye axial length. OCT cross
sections are used to evaluate the optic disc and retinal layers such as the retinal nerve fiber
layer (RNFL). Scan patterns that enabled reproducible measurements were developed, and
these eventually became incorporated into commercial systems. In 2000 Zangwill et al
published a study comparing OCT nerve fiber thickness values against stereo photography
and threshold visual field results showing that the OCT shows promise for providing quan‐
titative measures of RNFL thickness for diagnosing and monitoring glaucoma. [5]
With these improvements in speed and sensitivity as seen in spectral domain OCT, it is now
feasible to collect volumetric (three-dimensional; 3D) scans of tissue, whereas in the past, the
amount of time required to do this would have been prohibitive. Broadband volumetric retinal
imaging with SD-OCT have demonstrated speeds of up to 312,500. To date, most clinical
systems operate at an acquisition rate of ∼27,000 A-scans/s and an axial resolution of 5 to 6 μm.
The unprecedented speed and versatility of current forms of OCT have given us a new and
vast data set, allowing us to seek out specific retinal measurements that are most highly specific
for the diagnosis and observation of glaucomatous progression. Having the capacity to observe
tissue at a cellular level, we now can more aptly compare between individuals and with specific
Figure 8. GDX ONH image
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individuals over time. The additional information at hand also allows us to emerge from cup/
disc ratio, the age old and weather beaten descriptive of the nerve in the context of glaucoma.
It is now possible to look far deeper into retinal and nerve attributes and across a wider
diameter of retina, to look for structural changes that are most highly pathognomonic of
glaucoma and its progression. [6]
Figure 9. OCT crossectional view of the optic nerve
Figure 10. OCT three dimensional optic nerve scan
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5. Measuring the nerve
5.1. Cup Disc Ratio (C/D)
In quantifying glaucoma risk and severity, the C/D ratio of the optic nerve has been the
standard bearer during the past one hundred years. An eye with a low ratio was considered
less apt to be glaucomatous and, if glaucoma was diagnosed, was known to be less advanced.
High ratios implied high risk and or advanced disease. Some investigators noted that that the
significance of a specific C/D value would vary widely depending on the diameter of the nerve
itself. Investigators also began to note that nerve attributes such as rim thickness can be quite
meaningful. For example, given two nerves with C/D=.50, one may have a well centered cup
and no glaucomatous visual field loss, while another,.50 nerve, with loss if the inferior margin
may show a severe superior nasal field defect. To further confuse the notion of C/D, more
recent attention has been given to disc diameter and its implications on the significance of
C/D in individual patients. Our current understanding is that nerve diameter plays a large role
in the relative value of C/D. A C/D of.60 with a relatively small nerve is likely to have far greater
implications with regard to glaucoma than the same C/D in a large nerve.
Given the additional perspective of the influence of cup position and nerve diameter, it should
be easy to understand the now diminished value of C/D as a singular descriptive value of the
state of disease. Reminiscent of the loss of relevance of the age old “21 mm Hg” standard, our
current understanding of the scope of changes that occur within the nerve, surrounding the
nerve and, more recently, those changes in the axonal bed and the peri papillary ganglion cell
layer, further disenfranchises C/D and the meaningful descriptive of structural change in
glaucoma.
5.2. Retinal nerve fiber layer
Technologies  such as  GDX and,  more  recently,  OCT provide  nerve  fiber  measurements
outside of the boundaries of the disc and it has become evident that axonal changes in the
area  surrounding  the  nerve  are  important  in  understanding  the  nature  and  severity  of
glaucoma. [7, 8]
In a study performed by Bowd et al, clearly revealed that OCT revealed statistically significant
quantitative differences in RNFL thickness between OHT and normal eyes within their study
population. [9]
Additional studies such as those performed by Garas (2009), Sehi (2009) and Savini (2009)
(table 1) have helped develop greater confidence in our ability to clinically determine RNFL
thickness and to evaluate those findings in comparison to a reasonable field of normative
data. [10-12]
Similar investigations in the following years helped give confidence that there was finally a
method of determining RNFL thickness that was reliable enough so that meaningful compar‐
isons could be made between normal and glaucomatous subjects. Beyond that general
comparison, investigators could search for specific nerve and other retinal attributes which
are more specific to the diagnosis and management of glaucoma. In 2010, Mansoori et al
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showed that SD-OCT identified differences in most parameters between eyes with glaucoma
and normal eyes and also between eyes with glaucoma and OHT. It was important to note that
they also observed that there was overlap of RNFL thickness between normal and OHT eyes,
which somewhat limits the ability of this instrument to differentiate between normal and OHT
subjects.[13]
              Garas Sehi              Savini
Mean Std. 95% Mean Std. 95% Mean Std. 95%
Dev. Normal Normal Dev. Normal
Range Range Range
Average 106.7 7.5 91.7 to 103.3 12.6 78.1 to 105.8 14.9 76.7 to
RNFL 121.7 128.5 135.6
Superior 128.8 12.8 103.2 to 134.5 18.6 97.3 to 128.44 24.48 83.48 to
154.4 171.1 173.4
Inferior 136.6 12.7 111.2 to 129.7 16.9 95.9 to 137.15 21.99 93.17 to
162 163.5 181.13
S/ I 0.943 1.037 0.936
Ratio
Table 1. Retinal nerve fiber layer thickness averages in normal patients. Garas et al 2009 (14 normals), Sehi et al (20
normals) and Savini et al (23 normals)
5.3. Ganglion cell layer
Most recently, the new abundant source of data rendered via spectral domain OCT measure‐
ments, allow us to document structural changes in the axonal bed as well as other retinal layers
which were thought to, possibly, have close association with some types of glaucomatous
progression. It seems intuitive that failing nerves might show changes at their endpoints before
doing so in their mid-sections. Additionally, it seemed likely that axonal ganglia might show
changes in concert with various types of axonal demise. Studies such as those conducted
Desatnik et al and Ziemer et al in the 1990’s helped point us to our new appreciation of the
value of perimacular measurements. [14, 15]
Determining the extent of retinal ganglion cell loss may prove to be a superior method for
identifying glaucomatous progression. The loss of these cells leads to functional deficits and
structural changes in the retinal nerve fiber layer (RNFL). In their efforts to correlate structural
and functional loss in glaucoma, Harwerth and associates showed that the number of retinal
ganglion cells can be reliably estimated from either visual field sensitivity data or from OCT
RNFL analysis. [16]
6. Functional measurement
6.1. Subjective testing
The first record of a visual field defect is found in Hippocrates description of a hemianopia
from the late fifth century B.C. Ptolemy (150 B.C.) first attempted to quantify the visual field
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Figure 11. The RTVue scanning zones for assessment of the peripapillary retinal nerve fiber layer (RNFL) and the gan‐
glion cell complex (GCC)
Figure 12. Optovue OCT report showing RNFL and GCC thickness. Colors green, yellow and red indicate normal, bor‐
derline and abnormal (low) findings.
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and noted its circular form. According to Lloyd, Galen was the first physician "to record a
recognition of Extramacular fields." He suggests the first illustration of the visual field was
published in an article by Ulmus of Padua in 1602.
Early in the sixteenth century (about 1510) Leonardo da Vinci recognized that temporally the
visual field reaches around more than 90 degrees from fixation. He said (Manuscript D. folio
8 verso), "the eye sees those objects behind it that are placed in lateral areas." He suggested
that the cornea and the aqueous served to bend the light rays into the eye.
Figure 13. DaVinci’s Illustration of rays approaching the cornea from different directions
Von Graefe (below) is credited with introducing perimetry into clinical medicine. In 1855, at
the age of 28, he published "Examination of the Visual Functions in Amblyopic Affections."
Von Graefe built on the work of Helmholtz. Helmholtz had recommended that, in order to
keep one’s bearing during the examination of the ocular fundus, a numbered grid be placed
in front of the patient to direct the patient’s eye into certain known directions of gaze. It was
a piece of blackboard marked in this way that von Graefe used as a tangent screen. He worked
at a distance of 18 inches and used as a test object a piece of white chalk, about 1 cm across,
held in a wire. He made use of various symbols and dots as a fixation point so that the patient
could recognize his deficits more easily. [17]
It was not until the late 1980’s, when automated perimetry became widely available, that
manual methods of visual field assessment were finally outpaced as the clinical standard. With
the newfound ability to determine the relative depth of defect of a given point, clinicians had
the ability to appreciate a three dimensional plot of one’s visual status.
The introduction of computers and automation heralded a new era in perimetric testing. Static
testing can be performed in an objective and standardized fashion with minimal perimetrist
bias. A quantitative representation of the visual field can be obtained more rapidly than with
manual testing. The computer allows stimuli to be presented in a pseudorandom, unpredict‐
able fashion. Patients do not know where the next stimulus will appear, so fixation is improved,
thereby increasing the reliability of the test. Random presentations also increase the speed with
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which perimetry can be performed by bypassing the problem of local retinal adaptation, which
requires a 2-second interval between stimuli if adjacent locations are tested.
Figure 14. Albrecht von Graefe
Figure 15. The normal island of vision. The hill is highest at fixation, where visual sensitivity is greatest. The height of
the hill of vision declines toward the periphery as visual sensitivity diminishes.
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Any clinically or statistically significant deviation from the normal shape of the hill of vision
can be considered a visual field defect. In glaucoma, these defects are either diffuse depressions
of the visual field or localized defects that conform to nerve fiber bundle patterns. [18]
6.2. Current choices in subjective functional testing
The addition of computerization to assessment of the eyes functional performance led the way
to the development of several testing alternatives. Early white on white threshold testing
strategies were followed with faster and more efficient programs such as Humphries Swedish
Interactive Testing Algorithm (SITA) and the Haag-Streit Tendency Oriented Perimetry (TOP),
Along with unenhanced test specificity, both strategies significantly reduce testing times by
over 70%. The TOP strategy requires less than three minutes per eye per test.
A daunting point of frustration with the limits of threshold analysis came from the under‐
standing that significant axonal loss had to have occurred before a repeatable threshold could
be demonstrated. In 1982, Quigley reported that as much as 40% of optic nerve fibers may be
lost before significant threshold visual field loss. [19]
Alternatives more recent methods in subjective field analysis, such as short wavelength (blue
– yellow) and flicker strategies, were developed with the goal of reliably eliciting subject
glaucomatous defects at an earlier point the progression of the disease. It is now shown that
the flicker type tests such as Frequency Doubling Technology will have a role to play as a
glaucoma screening tests, where as the the blue-yellow tests may not be as predictive as once
throught. 20 Recently, there has been increased inteest in 10 degree white on white threshold
fields because of its greater test point density and its apparent structure relationship to new
OCT ganglion cell complex (GCC) imaging analyses. 14, 15
6.3. Objective testing
Objective methods such as Visual Evoked Potential (VEP), pattern electroretinography (pERG)
(Diopsys, Inc.), and Relative Afferent Pupillary Defect (RAPDx) (Konan, USA) offer the
potential of earlier and more specific functional testing but here continues to be a need to more
reliably access functional loss at an earlier point in glaucomagenesis. While VEP and pERG
measure the relative integrity of the electrical signal that passes through the nerve during the
visual process,
RAPDx expands on the notion of diminished afferent pupillary reflex that may occur as nerve
integrity is lost and glaucoma progresses.
With newer imaging methods such as OCT, we have made significant strides in earlier
detection of structural loss, while our ability to detect functional loss earlier than what we
achieve via white on white threshold field analysis remains a challenge. Given early evidence
that VEP, pERG and RAPDx may offer some reliable evidence of early functional change, one
can only hope that robust scientific evidence paired with more technical advancement of these
types of tools may help us get a bit closer. [21-23]
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Figure 16. Visual Evoked Potential (VEP), pattern electroretinography (pERG) (Diopsys, Inc.)
Figure 17. RAPDx (Konan, USA) measures Relative Afferent Pupillary Defect
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7. Combining structural and functional data to optimize specificity in
diagnosis
Along with our better understanding of the various limitations of either structural or functional
analysis as a singular metric for glaucoma management, the obvious question has become can
we, somehow, fortuitously coalesce both data sets? By combining the two, can we apprehend
glaucoma earlier in its progression and develop better methods of dividing glaucoma into
more meaningful subtypes? Will doing so allow us to treat more promptly, effectively and
more specifically? Finally, is there a way to combine structural tests with functional tests to
give us some type of unified glaucoma value?
Several investigators pioneered early structure function studies with the goal of establishing
a better understanding of the relationships between various structural and functional values.
In 1976, Stephen Drance described optic disc changes as they correlated to visual field defects
in chronic open-angle glaucoma. Drance’s studies were followed by Hoskins et al and
Hitchings et al who also observed the nature of optic changes which occurred in concert with
glaucomatous visual field changes (ref’s). [24-26] These investigations were conducted with
the goal of pairing specific anatomical changes commonly associated with glaucoma with
associated functional (visual field) changes. Others tried to find a common more useful value
in combining structural and functional data in different ways. [24-26]
Perhaps, the most renowned investigations which have established the foundations of our
current understanding of the structure function relationship were performed by Quigley et al
during the 1980’s. Glaucomatous eyes were studied posthumously to determine how the
number and distribution of human optic nerve axons compared with clinical measurements
available the same eyes, including visual acuity, disc appearance, and visual field studies.
Quigley reported that definite loss of axons occurs prior to reproducible visual field defects in
some patients suspected of having glaucoma. In glaucoma, the superior and inferior poles of
the nerve lose nerve fibers at a selectively greater rate, leading to an hourglass-shaped atrophy.
He also reported that the pattern of atrophy in examples of toxic amblyopia, ischemic optic
neuropathy and chronic papilledema differ from that of glaucoma, suggesting different
mechanisms of damage in these conditions.
In later investigations, Harwerth et al described relationships between field loss and retinal
ganglion cells. The data were analyzed by a model that predicted ganglion cell densities
from standard clinical perimetry, which were then compared to histologic cell counts. Their
work became part of the foundation for our current interest and understanding of function‐
al loss in the context of retinal tissue changes beyond the losses previously described in
retinal axons. [27-30]
In 2005, Gardiner et al produced a topographical map to demonstrate how sectors of the optic
nerve head (ONH) are related to locations in the visual field, using empiric cross-sectional
patient data. They observed one hundred nine subjects with healthy eyes and 166 subjects with
diagnosed or suspected glaucoma (one test per patient) were evaluated using a Heidelberg
Retina tomograph (HRT) and white-on-white standard automated perimetry (SAP). The
Ophthalmology - Current Clinical and Research Updates240
Tomograph ONH images were divided into 36 sectors; and the sector rim areas normalized to
account for changes in the total rim area. These were then correlated with SAP thresholds. For
each visual field location, a map was produced indicating the strength of correlation between
the normalized sector rim areas and thresholds. Their efforts resulted in a map relating regions
of the ONH to SAP test locations. This map may be useful in elucidating the structure-function
relationship, particularly for cases of localized glaucomatous loss.
Their results also indicate that narrowing of the neuroretinal rim in some areas appeared to
be more significant than in others, in terms of predicting functional loss; in particular in the
polar areas of the ONH. This may account for some of the limitations of predictive power that
has been shown of global HRT indices. [31]
In 2010, Harwerth et al attempted to build a model of these linking propositions using data
from investigations of the relationships between losses of visual sensitivity and thinning of
retinal nerve fiber layer over progressive stages of glaucoma severity. A foundation for the
model was laid through the pointwise relationships between visual sensitivities (behavioral
perimetry in monkeys with experimental glaucoma) and histological analyses of retinal
ganglion cell densities in corresponding retinal locations. The subsequent blocks of the model
were constructed from clinical studies of aging in normal human subjects and of clinical
glaucoma in patients to provide a direct comparison of the results from standard clinical
perimetry and optical coherence tomography. The final formulation is a nonlinear structure-
function model that was evaluated by the accuracy and precision of translating visual
sensitivities in a region of the visual field to produce a predicted thickness of the retinal nerve
fiber layer in the peripapillary sector that corresponded to the region of reduced visual
sensitivity. The model was tested on two independent patient populations, with results that
confirmed the predictive relationship between the retinal nerve fiber layer thickness and visual
sensitivities from clinical perimetry. Thus, the proposed model for linking structure and
function in glaucoma has provided information that is important in understanding the results
of standard clinical testing and the neuronal losses caused by glaucoma, which may have
clinical application for inter-test comparisons of the stage of disease. The model was tested on
two independent patient populations, with results that confirmed the predictive relationship
between the retinal nerve fiber layer thickness and visual sensitivities from clinical perimetry.
Thus, the proposed model for linking structure and function in glaucoma has provided
information that is important in understanding the results of standard clinical testing and the
neuronal losses caused by glaucoma, which may have clinical application for inter-test
comparisons of the stage of disease. [16]
In 2012, Medeiros et al confirmed that an index combining structure and function performed
better than isolated structural and functional measures for detection of perimetric and
preperimetric glaucoma as well as for discriminating different stages of the disease. Observa‐
tional study included 333 glaucomatous eyes (295 with perimetric glaucoma and 38 with
preperimetric glaucoma) and 330 eyes of healthy subjects. All the eyes were tested with
standard automated perimetry and spectral domain optical coherence tomography within 6
months. Estimates of the number of retinal ganglion cells (RGCs) were obtained from standard
automated perimetry and spectral domain optical coherence tomography and a weighted
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averaging scheme was used to obtain a final estimate of the number of RGCs for each eye. The
CSFI was calculated as the percent loss of RGCs obtained by subtracting estimated from
expected RGC numbers. The performance of the CSFI for discriminating glaucoma from
normal eyes and the different stages of disease was evaluated by receiver operating charac‐
teristic curves. [32, 33]
Figure 18. Polar analysis of a threshold visual field showing severity of the defect in concert with nerve anatomy.
While traditional graphical reports of field analysis show projected (inverted) findings, the polar analysis is anatomical‐
ly correct.
In 2013, Meira-Freitas et al demonstrated that baseline and longitudinal estimates of retinal
ganglion cell counts based on combined structure and function tests may be helpful in
predicting progression, and performed significantly better than conventional approaches for
risk stratification of glaucoma suspects. The study included 288 glaucoma suspect eyes of 288
patients followed for an average of 3.8 ± 1.0 years. Estimates of RGC counts were obtained by
combining data from SAP and OCT according to previously described method. Joint longitu‐
dinal survival models were used to evaluate the ability of baseline and rates of change in
estimated RGC counts for predicting progression over time, adjusting for confounding
variables. [34]
Also, in 2013, Le et al implemented fourier-domain optical coherence tomography (FD-OCT)
system to map the macula and peripapillary regions of the retina in 56 eyes of 38 patients with
perimetric glaucoma. The macular GCC and peripapillary NFL thicknesses were mapped and
standard automated perimetry (SAP) was performed. Loss of GCC and NFL were correlated
with the VF map on both a point-by-point and regional basis, showing that there are significant
point-specific and regional correlations between GCC loss, NFL loss, and deficits on SAP. Their
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findings suggest that using these different data sources together may improve our under‐
standing of glaucomatous damage and aid in the management of patients with glaucoma. [35]
In 2013, Hye-Young Shin et al Two hundred and thirteen eyes of 213 patients with glaucoma
were observed to explore and compare the relationships between the visual field (VF)
sensitivities assessed by standard automated perimetry (SAP) and the ganglion cell inner
plexiform layer (GCIPL) and peripapillary retinal nerve fiber layer (pRNFL) thicknesses as
measured by Cirrus high-definition optical coherence tomography (HD-OCT) in glaucoma‐
tous eyes.
The average and sectorial GCIPL thicknesses determined by Cirrus HD-OCT were signifi‐
cantly associated with global and regional VF sensitivity in patients with glaucoma. They
concluded that the macular GCIPL thickness values may provide more valuable information
than temporal profile thickness values for understanding the structure–function relationships
of the macular region. [35]
In 2013, Marín-Franch et al reported their comparison structural and functional damage from
glaucoma often using statistical methods such as linear regression, which was agreed to have
limitations that can lead to inadequate clinical recommendations. These limitations were
analyzed, using examples from the literature. Inferences from linear regression are model
dependent. They concluded that tests of linear relations between structure and function in
glaucoma may be improved by the use of Deming regression, although its application requires
knowledge about test-retest variability of measures of glaucomatous damage. [37, 38]
8. Summary
It has been said that in Einstein's Grand Quest for a Unified Theory “He failed, of course, but
he didn't exactly waste his time.” Similarly, our search for a simplified common denominator
to describe glaucoma in a simple way is likely to fail. Our methods of documenting the optic
nerve and various ocular structures related to the genesis of glaucoma have evolved from
direct observation paired with hand drawings to ocular corherance tomographic devices,
which render elegant cross sectional views with as little as 5 microns of resolution. Quantifi‐
cation of the visual field has also evolved to sophisticated threshold subjective analyses and
promising new objective strategies. In spite of this impressive technical evolution, we have yet
to agree upon a practical combination of structural and functional data that can provide a
single metric for risk of glaucoma and the level of its progression.
Perhaps, the solution to this conundrum can be derived from our acceptance that glaucoma
does not appear to be one simple disease, but rather one that is the result of a litany of risk
factors that commonly result in the untimely deterioration of the optic nerve. As investigators
have and continue to examine the many structural and functional changes that may occur in
the process of glaucoma, the field of clinical variables ironically seems to expand rather than
contract. Physical changes may be observed at the neural retinal rim first, while in other
patients changes in the peri macular ganglion cell layer may be the first signal of glaucomatous
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change. Some patients might show degradation in their peripheral visual fields while others
seem to start with central changes. Recent investigators have even suggested that early
changes, in glaucoma, may occur within the brain.
As with Einstein’s Grand Quest, it can be argued that the efforts of researchers to find a “unified
glaucoma value” have not been a waste of time. While there seems to be no simple solution to
this puzzle in sight, we have been given a far better understanding of glaucoma’s multivariate
etiology which should enable more specific and prompt diagnosis and, ultimately, more
specific and effective glaucoma therapies.
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